Recursion Pharmaceuticals (RXRX) Shares Outstanding (Entity) (2020 - 2026)
Recursion Pharmaceuticals' Shares Outstanding (Entity) was 534.12 million in Q2 2026, up 23.4% from 432.83 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Shares Outstanding (Entity) (2020 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Entity) at Recursion Pharmaceuticals came in at 528.18 million, up 33.2% from FY2024.
- Shares Outstanding (Entity) has now increased for five consecutive years, with a five-year compound annual growth rate of 25.7% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Entity) was 396.51 million in FY2024 (+69.3%), 234.27 million in FY2023 (+22.6%), 191.02 million in FY2022 (+12.2%) and 170.27 million in FY2021 (+1.1%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2020.
- Compared with a year earlier, Shares Outstanding (Entity) has increased for 20 straight quarters, with growth averaging 48.2% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.1% (Q3 2021) to 71.9% (Q3 2025).
- Per Business Quant data, RXRX's Shares Outstanding (Entity) in the three quarters before Q2 2026 was 530.63 million (Q1 2026), 528.18 million (Q4 2025) and 491.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn | 534.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 534.12 Mn |
| Mar 31, 2026 | 530.63 Mn |
| Dec 31, 2025 | 528.18 Mn |
| Sep 30, 2025 | 491.80 Mn |
| Jun 30, 2025 | 432.83 Mn |
| Mar 31, 2025 | 406.41 Mn |
| Dec 31, 2024 | 396.51 Mn |
| Sep 30, 2024 | 286.12 Mn |
| Jun 30, 2024 | 280.97 Mn |
| Mar 31, 2024 | 237.51 Mn |
| Dec 31, 2023 | 234.27 Mn |
| Sep 30, 2023 | 216.31 Mn |
| Jun 30, 2023 | 206.74 Mn |
| Mar 31, 2023 | 192.23 Mn |
| Dec 31, 2022 | 191.02 Mn |
| Sep 30, 2022 | 174.07 Mn |
| Jun 30, 2022 | 172.82 Mn |
| Mar 31, 2022 | 171.08 Mn |
| Dec 31, 2021 | 170.27 Mn |
| Sep 30, 2021 | 168.63 Mn |
API Access
Recursion Pharmaceuticals Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();